Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
What are your preferred dose/fractionation options for treatment of hemoptysis related to central lung metastasis?
Does your management change if the primary tumor is radioresistant, such as renal cell carcinoma?
Answer from: Radiation Oncologist at Community Practice
50 Gy in 5 fractions every other day with SBRT.
Sign in or Register to read more
15235
Related Questions
Would you consider spine re-irradiation after Pluvicto?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
Do you have a 15 fraction constraint for the LADA?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
Would you offer a third course of palliative radiation after two courses of 8 Gy in 1 fx?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?